Daily as of 3 Nov 16:00 ET
- Price
- above both $42.47 vs 50 $40.91 / 200 $33.38
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 5 Sep 2025 ยท projected 25 bars out
iShares Genomics Immunology and Healthcare ETF (IDNA) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 23 Mar 2026 | ๐จGolden moderate | weekly | 30 bars out | Not tested |
| 5 Sep 2025 | ๐จGolden moderate | daily | 25 bars out | Not tested |
| 30 Dec 2024 | ๐Death | daily | 25 bars out | 1 bar cross test |
| 2 Feb 2024 | ๐จGolden | daily | 28 bars out | 2 bar cross test |
| 13 Jul 2023 | ๐จGolden | 4-hour | not projected | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.